Stockhub

Crossject Société Anonyme: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 August 2022

  • curprev 00:2100:21, 18 August 2022 >Paris 805 bytes +805 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone us..."
Retrieved from "https://stockhub.co/research/Crossject_Société_Anonyme"